Health Condition 1: R351- Nocturia
Conditions
Interventions
Intervention1: Melatonin receiver: Patient with complain of nocturia will be provided 2mg melatonin per oral will be given for 2 weeks and outcome will be measured after 2 weeks.
Control Intervention
Sponsors
Institute based thesis
Eligibility
Inclusion criteria
Inclusion criteria: Women with mean nocturnal voiding frequency of at least one episode per night as determined by 3 day bladder diary
Exclusion criteria
Exclusion criteria: 1.Neurological or psychological abnormalities 2. History of drug allergy or side effect from melatonin 3.Hepatic or renal dysfunction 4.uncontrolled diabetes mellitus 5. Diabetes insipidus 6. Cardiovascular disease 7.Urinary tract infection 8.Stage 3 pelvic organ prolapse 9.Urinary retention 10. Current smoker
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease in occurrence of nocturiaTimepoint: Baseline, 2 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Frequency of urination during day 2.Amounts of urine voided throughout the day and at night 3. Index measuring excessive nighttime urination 4. Maximum volume voided during urination 5. Duration of sleep 6. Quality of life assessmentTimepoint: 2 weeks | — |
Countries
India
Contacts
Public ContactDr Nisha
AIIMS NEW DELHI
Outcome results
None listed